Geschiedenis van PIP-man in Amerika

McGhan banden met PIP

Dochteronderneming PIP Hertitage

Medicor met handelsnaam PIP

Drie bedrijfsleiders PIP overleden

Testing component evaluation report for design examination 2004

Meldpunt Klachten Siliconen over PIP

9 mei 2013

Chemical in faulty breast implants used by up to 47,000 women in UK 'causes damage to unborn babies' >>

Faulty PIP implants may pose pregnancy risk, according to experts

Health officials say chemicals used to make them are of' high concern'

PIP implants already under fire for being more likely to rupture

Women with faulty PIP breast implants are at risk of chemical exposure that causes damage to unborn babies, experts have warned.

Their report disputes previous warnings by the NHS that material inside the implants was ‘not toxic or carcinogenic’.

The scientists are now calling for an inquiry into the potential side effects of PIPs.

Up to 47,000 British women could have received the French implants which were fraudulently filled with an industrial-grade silicone designed for mattresses.

Testing has previously revealed that PIP implants were up to six times as likely to rupture as other brands.

Writing in the Journal of the Royal Society of Medicine, the group of experts called for women to be given ‘full information’ by British authorities.

The consumer protection group Antidote Europe said it disagreed with a report by the British Medicines and Healthcare Products Regulation Authority (MHRA) that suggested the implants did not contain hazardous materials.

The body identified dangerous levels of chemicals in the implants, with one known as D4 being deemed of ‘high concern’ by European health officials.


Exercise reduces risk of breast cancer because it changes the way body uses oestrogen

Antidote Europe director and co-author of the report, Andre Menache, said: ‘Considering these known risks and the fact that most women receiving breast implants were of reproductive age, we would expect the MHRA and the Department of Health to fulfil its duty of care and thoroughly investigate these risks as well as provide full information to patients.’

The report says that thorough analysis of the gel within the PIP implants has yet to be carried out and also points towards possible contamination with lead, platinum and zinc during production